IPO
Motif Bio plc of the Company held earlier in New York, all resolutions put to shareholders were duly passed.
Board includes experts from Case Western Reserve University, Duke University, University of Pittsburgh and Washington University in St. Louis
Establishing a New Gene Therapy Drug Process Development Building and Expanding Product Facilities in Texas, USA
ADL Bionatur Solutions, a company specialized in the research and development of health, cosmetic and beauty products, services and industrial fermentation production, reported financial results for the third quarter and first nine months of 2019.
Strategic investment in the US-based company complements Advanced MedTech’s non-invasive product portfolio and strengthens its leadership in urology and stone management
Over 15,000 patients worldwide already treated with Letermovir to prevent Cytomegalovirus (CMV) infection and disease in allogeneic stem cell transplantation
Actuate Therapeutics, Inc., a clinical stage biopharmaceutical company, announced it has raised an additional $6.5M in a Series B-3 financing round.
Secarna Pharmaceuticals, a new breed of biopharmaceutical company focusing on the discovery and development of antisense oligonucleotide therapies to address challenging or previously undruggable targets, announced that the Company has completed a financing round, which was open only to existing investors.
Generates over USD 1 million in sales through new POCare platform
Recently announced results of open label extension part of SHINE Phase IIb study confirm potential of IFX-1 in Hidradenitis Suppurativa and warrant evaluation of future development
PRESS RELEASES